Related Experiment Video
Updated: Oct 16, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Potential nephroprotective phytochemicals: Mechanism and future prospects.
Parakh Basist1, Bushra Parveen1, Sultan Zahiruddin2
1Bioactive Natural Product Laboratory, Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India; Department of Pharmacology, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India.
This review explores nephroprotective (NP) phytoconstituents for kidney disease (KD) management. It highlights their mechanisms, sources, and clinical efficacy, offering a scientific basis for natural treatments.
Area of Science:
- Pharmacology
- Ethnobotany
- Nephrology
Background:
- Kidney disease (KD) presents a significant global health and economic challenge.
- Current KD treatments often have severe side effects and poor patient adherence.
- Phytoconstituents offer a promising avenue for nephroprotection (NP) with potential for improved safety and efficacy.
Purpose of the Study:
- To systematically review the global burden of KD.
- To evaluate phytoconstituents as NP agents, detailing their mechanisms (in vitro and in vivo).
- To assess the clinical efficacy of these agents in managing KD and related disorders.
Main Methods:
- A systematic literature search was conducted across major scientific databases (PubMed, Scopus, etc.) until February 2021.
- Screening of over 24,000 articles focused on phytoconstituents and kidney disorders.
- Inclusion of 236 high-quality studies detailing nephroprotective mechanisms, plant sources, and clinical data.
Main Results:
- Identified numerous phytoconstituents with demonstrated nephroprotective potential.
- Documented diverse biological sources and multiple mechanisms of action for these compounds.
- Compiled research-based evidence on their efficacy in preclinical and clinical settings.
Conclusions:
- Pre-clinical and clinical data support the use of NP phytoconstituents for KD management.
- Further clinical studies are needed to enhance understanding of their pharmacodynamics and pharmacokinetics.
- More specific evaluations of natural sources are required for optimized therapeutic development.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Potassium-Sparing Diuretics
Renal Drug Excretion: Tubular Secretion
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Heart Failure Drugs: Diuretics

